January 2020 PMID 31914999

New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.

Yanhong Guo, Qin Wang, Chunyan Lu, Pianpian Fan, Jing Li, Ximing Luo, Decai Chen

Full text PDF Download social card

Mentions

Peak: 1 in Jan 2020

across 2 sources since Jan 2020

Extended reach

5,452

potential audience

Total likes

Video views

4,331

Mentions per month

Jan 2020 – Dec 2021

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

The majority of discussions emphasize the promising diagnostic capability of the PFindex, highlighting its potential to improve clinical decision-making, with words like ‘differentiating’ and ‘screening tool’ underscoring its importance. This tone reflects strong support and high engagement with the article's implications for healthcare practice.

AgreementStrong agreement

Most discussions acknowledge the effectiveness of the new PFindex in distinguishing hyperparathyroidism types, with posts citing cutoff values and clinical relevance.

InterestHigh interest

Posts show high interest by focusing on specific diagnostic improvements and potential clinical applications, like differentiating NPHPT from VDSHPT.

EngagementHigh engagement

Several discussions delve into the methodology and significance, indicating a deep engagement with the research findings.

ImpactModerate impact

The discussions suggest this index could significantly influence clinical diagnostics, though some posts hint at the need for further validation, making the impact somewhat cautious.

Abstract in brief

The study introduced a new parathyroid function index (PFindexCaPTHPBR) to help differentiate primary hyperparathyroidism (PHPT), including its normocalcemic form (NPHPT), from vitamin D deficiency-related secondary hyperparathyroidism (VDSHPT), since these conditions are hard to distinguish based on calcium and PTH levels alone.
The research showed that the PFindex was significantly higher in PHPT patients compared to NPHPT, VDSHPT, and healthy controls, with a cutoff value of 34 providing high sensitivity and specificity for diagnosing PHPT and NPHPT.
The PFindex demonstrated excellent diagnostic ability, especially in distinguishing NPHPT from VDSHPT, suggesting it could be a useful, simple screening tool in clinical settings to accurately diagnose different hyperparathyroidism conditions.]

Read the full abstract

All mentions

Understanding Parathyroid Disorders and Calcium Homeostasis

This presentation covers diseases of the parathyroid glands and calcium balance, including radiation impact on the parathyroid, calcium sensing receptors, and management of primary hyperparathyroidism, providing…

Johannes W. Dietrich · May 30, 2020 4,331 views

Sallie Powell

@SpSallie · X

RT @Aureliano241972: PFindex (PFindex = Ca*PTH/P) > 34 to differentiate #normocalcemic #primary #hyperparathyroidism from #vitaminD deficie…

Dec 20, 2021 · 1 share · 883 followers View post →

Maurizio Merico

@Aureliano241972 · X

PFindex (PFindex = Ca*PTH/P) > 34 to differentiate #normocalcemic #primary #hyperparathyroidism from #vitaminD deficiency-induced secondary hyperparathyroidism https://t.co/edSRtzR79U

Jan 9, 2020 · 2 likes · 1 share · 235 followers View post →